On November 2, 2021 Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, reported the Company will release its third quarter 2021 financial results before the market opens on Wednesday, November 10, 2021 (Press release, Synlogic, NOV 2, 2021, View Source [SID1234594193]). The press release will be followed by a conference call at 8:30 am ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide a corporate update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference call dial-in numbers are (844) 815-2882 for domestic callers and (213) 660-0926 for international callers. The conference ID number for the call is 5450919. Participants may access the live webcast via a link on the Synlogic website in the Events Calendar of the Investors and Media section. For those unable to participate in the conference call or webcast, a replay will be available for 30 days on the Company’s website.

Additionally, Aoife Brennan, M.B. Ch.B., Synlogic’s President and Chief Executive Officer, will present at the following banking conference:

Jefferies London Healthcare Conference, November 18th and 19th. The Company presentation will be available on demand.
Synlogic’s pre-recorded session will be available for the duration of the conference and a replay will be available for 30 days on the Company’s website.